Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
Top Cited Papers
- 12 May 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 357 (9267) , 1478-1484
- https://doi.org/10.1016/s0140-6736(00)04644-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Lung CancerAnnals of Oncology, 2000
- Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II studyAnnals of Oncology, 1999
- Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)Lung Cancer, 1998
- Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trialAnnals of Oncology, 1996
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerCancer, 1995
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- A Randomized Trial with Mitomycin-C/Ifosfamide Versus Mitomycin-C/Vindesine Versus Cisplatin/Etoposide in Advanced Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- Reporting results of cancer treatmentCancer, 1981